Arcus Biosciences, Inc. Announces Pricing of $302.5 Million Underwritten Public Offering of Common Stock Portfolio News / By Karina Tin May 28, 2020
Circle Pharma Appoints William G. Kaelin Jr. MD as Chair of Its Scientific Advisory Board Portfolio News / By Karina Tin May 27, 2020
Arcus Biosciences and Gilead Sciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies Portfolio News / By Karina Tin May 27, 2020
NGM Bio Appoints Siobhan Nolan Mangini as Chief Financial Officer Portfolio News / By Karina Tin May 27, 2020
ORIC Pharmaceuticals Reports First Quarter 2020 Financial and Operational Results Portfolio News / By Karina Tin May 20, 2020
RAPT Therapeutics Reports First Quarter 2020 Financial Results Portfolio News / By Karina Tin May 14, 2020
Revolution Medicines Reports First Quarter 2020 Financial Results and Continued Corporate Progress Portfolio News / By Karina Tin May 14, 2020
Constellation Pharmaceuticals Provides Update of Preliminary Data for CPI-0610 in Three EHA Abstracts Portfolio News / By Karina Tin May 14, 2020
NGM Bio Provides Business Update and Reports First Quarter 2020 Financial Results Portfolio News / By Karina Tin May 13, 2020
Gritstone Oncology Reports First Quarter Financial Results and Recent Highlights Portfolio News / By Karina Tin May 7, 2020
